Stay updated with breaking news from Opgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of OpGen (NASDAQ:OPGN – Get Rating) from a sell rating to a hold rating in a research report report published on Tuesday morning. OpGen Stock Down 2.5 % Shares of OPGN opened at $0.69 on Tuesday. OpGen has a 52 week low of $0.55 and a 52 week high of $16.40. The […]
OpGen (NASDAQ:OPGN – Get Rating) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. OpGen Stock Performance OPGN remained flat at $0.70 on Tuesday. 58,086 shares of the company traded hands, compared to its average volume of […]
Precigen, Inc. (NASDAQ:PGEN – Get Rating) – Equities researchers at HC Wainwright dropped their Q2 2023 earnings per share (EPS) estimates for shares of Precigen in a research report issued to clients and investors on Thursday, May 11th. HC Wainwright analyst S. Ramakanth now forecasts that the biotechnology company will post earnings of ($0.09) per […]
OpGen has reported a productive quarter marked by advancements across the board. Operating loss improved to $5.1m during the quarter (from $5.8m in Q122), driven by 94% y-o-y top-line growth (to $0.9m)
OpGen, Inc. (NASDAQ:OPGN – Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 206,100 shares, an increase of 127.0% from the April 15th total of 90,800 shares. Approximately 3.8% of the shares of the stock are short sold. […]